Skip to content
Home/Companies/Biotech/Affibody AB

Affibody AB

Biotech·Sweden·Active·25yr hold
Entry
2001
Hold
25yr
Status
Active

Who owns Affibody AB?

Affibody AB is currently owned by HealthCap through HealthCap (early funds) (1996 vintage), since 2001.

Hand-verified · updated 2026-08-18

HealthCap
Investor
HealthCap
HealthCap (early funds) · 1996 · VC

Key facts

HQSweden
SectorBiotech
StatusActive

More from HealthCap (early funds)

Other portfolio companies in the same fund.

Pharmion Corp.
Exited 2003
PharmaUS· 2001
Gyros AB
Exited 2016
MedTechSweden· 2000
to
Cytos Biotechnology AG
Exited 2002
BiotechSwitzerland· 1999
Actelion Holding Ltd
Exited 2017
PharmaSwitzerland· 1997
to
Biotage AB (Pyrosequencing AB)
Exited 2000
BiotechSweden· 1997
Carmeda AB
Exited 2005
MedTechSweden· 1996
to

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track Affibody AB

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Affibody AB?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Affibody AB.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue